SLSN

+ Watchlist + Portfolio

Solesence, Inc.

Physical products Consumer brandTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.83
52-Week Range: $0.61 – $4.19
Market Cap: $57.93M
P/E (TTM): —
EPS (TTM): -0.04
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 4.41
PEG Ratio: —
Return on Equity: -18.55%
Return on Assets: -2.35%
Gross Margin: 25.04%
Operating Margin: 0.79%
Profit Margin: -5.25%
Current Ratio: 0.97
Debt/Equity: 1.73
Total Debt: $22.70M
Free Cash Flow: $3.19M
Revenue Growth: -24.70%
Earnings Growth: —
Enterprise Value: $79.58M

SLSN Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$37.32M	$37.30M	$52.35M	$62.06M
Cost of Revenue	$28.96M	$29.47M	$36.16M	$46.00M
Gross Profit	$8.36M	$7.83M	$16.19M	$16.06M
Research & Development	$3.04M	$3.84M	$3.84M	$4.09M
Selling, General & Admin	$7.58M	$7.53M	$7.22M	$10.40M
Operating Expenses	$10.62M	$11.37M	$11.06M	$14.49M
Operating Income	-$2.26M	-$3.55M	$5.13M	$1.57M
EBITDA	-$1.69M	-$2.80M	$6.06M	$3.69M
Pretax Income	-$2.64M	-$4.38M	$4.46M	$1.86M
Income Tax	-$17.00K	$6.00K	$227.00K	$73.00K
Net Income	-$2.62M	-$4.39M	$4.24M	$1.79M
Diluted EPS	-0.05	-0.09	0.07	0.02
Diluted Shares	49.12M	49.56M	65.03M	72.58M

SLSN Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$2.19M	$1.72M	$1.41M	$1.29M
Receivables	$4.73M	$3.47M	$4.87M	$6.84M
Inventory	$8.84M	$10.03M	$20.27M	$18.51M
Current Assets	$16.63M	$16.30M	$29.35M	$28.78M
Total Assets	$33.56M	$32.88M	$50.00M	$50.05M
Current Liabilities	$13.84M	$15.59M	$25.77M	$13.93M
Long-Term Debt	$4.00M	$6.00M	—	$10.50M
Total Debt	$18.11M	$21.26M	$15.30M	$24.32M
Total Liabilities	$27.91M	$30.98M	$35.06M	$32.42M
Retained Earnings	-$100.07M	-$104.66M	-$100.43M	-$98.64M
Shareholders' Equity	$5.65M	$1.90M	$14.95M	$17.63M
Working Capital	$2.79M	$713.00K	$3.58M	$14.85M
Net Debt	$6.10M	$9.09M	$3.59M	$13.98M

SLSN Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$1.65M	-$2.01M	$1.97M	-$8.57M
Capital Expenditure	-$2.82M	-$1.05M	-$4.56M	-$2.14M
Free Cash Flow	-$4.47M	-$3.06M	-$2.59M	-$10.71M
Depreciation & Amortisation	$567.00K	$742.00K	$928.00K	$897.00K
Stock-Based Compensation	$625.00K	$773.00K	$725.00K	$575.00K
Investing Cash Flow	-$2.82M	-$1.05M	-$4.56M	-$2.14M
Financing Cash Flow	$6.00M	$2.59M	$2.27M	$10.59M
Net Change in Cash	$1.53M	-$464.00K	-$313.00K	-$121.00K

SLSN Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$14.63M	$20.36M	$14.60M	$12.48M	$12.96M	$15.33M
Cost of Revenue	$11.24M	$13.92M	$11.23M	$9.05M	$9.62M	$10.58M
Gross Profit	$3.38M	$6.44M	$3.37M	$3.43M	$3.34M	$4.75M
Research & Development	$1.02M	$955.00K	$1.08M	$1.03M	$1.04M	$947.00K
Selling, General & Admin	$2.11M	$3.01M	$3.07M	$2.21M	$2.80M	$3.68M
Operating Expenses	$3.13M	$3.97M	$4.15M	$3.25M	$3.84M	$4.63M
Operating Income	$256.00K	$2.48M	-$781.00K	$186.00K	-$504.00K	$121.00K
EBITDA	$482.00K	$3.94M	-$556.00K	$395.00K	-$190.00K	$444.00K
Pretax Income	$80.00K	$3.62M	-$1.12M	-$154.00K	-$766.00K	-$158.00K
Income Tax	$0.00	$390.00K	$0.00	-$317.00K	$0.00	$0.00
Net Income	$80.00K	$3.23M	-$1.12M	$163.00K	-$766.00K	-$158.00K
Diluted EPS	0.00	0.04	-0.02	0.00	-0.01	0.00
Diluted Shares	72.63M	72.55M	70.50M	72.81M	70.63M	70.64M

SLSN Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$1.82M	$4.11M	$429.00K	$1.29M	$573.00K	$1.05M
Receivables	$9.09M	$11.05M	$9.71M	$6.84M	$6.38M	$9.35M
Inventory	$21.91M	$19.83M	$18.87M	$18.51M	$17.56M	$12.96M
Current Assets	$35.90M	$38.77M	$32.79M	$28.78M	$26.41M	$25.27M
Total Assets	$57.02M	$59.96M	$53.99M	$50.05M	$47.79M	$46.44M
Current Liabilities	$32.88M	$22.54M	$17.86M	$13.93M	$12.69M	$26.01M
Long-Term Debt	—	$10.50M	$10.50M	$10.50M	$10.50M	—
Total Debt	$22.56M	$26.31M	$25.18M	$24.32M	$22.28M	$22.70M
Total Liabilities	$41.86M	$41.77M	$36.76M	$32.42M	$30.83M	$33.28M
Retained Earnings	-$100.35M	-$97.68M	-$98.80M	-$98.64M	-$99.40M	-$103.31M
Shareholders' Equity	$15.16M	$18.19M	$17.23M	$17.63M	$16.97M	$13.15M
Working Capital	$3.03M	$16.23M	$14.93M	$14.85M	$13.72M	-$743.00K
Net Debt	$10.68M	$12.49M	$15.39M	$13.98M	$12.97M	$13.24M

SLSN Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$7.22M	-$654.00K	-$2.51M	$1.82M	$1.52M	$191.00K
Capital Expenditure	—	—	-$418.00K	-$450.00K	-$528.00K	-$469.00K
Free Cash Flow	-$7.22M	-$1.93M	-$2.93M	$1.37M	$989.00K	-$278.00K
Depreciation & Amortisation	$226.00K	$225.00K	$225.00K	$221.00K	$313.00K	$323.00K
Stock-Based Compensation	—	$120.00K	$122.00K	$206.00K	$83.00K	$79.00K
Investing Cash Flow	$133.00K	-$1.41M	-$418.00K	-$450.00K	-$528.00K	-$469.00K
Financing Cash Flow	$7.50M	$4.35M	-$750.00K	-$510.00K	-$1.70M	$751.00K
Net Change in Cash	$408.00K	$2.29M	-$3.68M	$859.00K	-$715.00K	$473.00K

Market Snapshot

About

Solesence, Inc. is a footwear and wellness company specializing in orthopedic and comfort footwear products. The company designs and markets products that combine therapeutic benefits with fashion-forward designs. Solesence focuses on addressing foot health issues while providing stylish options for consumers.